RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000018.xml
Facial Plast Surg 2013; 29(04): 295-309
DOI: 10.1055/s-0033-1349363
DOI: 10.1055/s-0033-1349363
Minimally Invasive Periorbital Rejuvenation
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
24. Juli 2013 (online)
![](https://www.thieme-connect.de/media/fps/201304/lookinside/thumbnails/10.1055-s-0033-1349363-1.jpg)
Abstract
Minimally invasive procedures have become increasingly popular over the last decade. In many cases, the use of neuromodulators and fillers has replaced surgical procedures. This article reviews the analysis and evaluation of the aesthetic patient presenting for periorbital rejuvenation. A layered approach is used, evaluating the skin, fat, muscle, and bone to determine which procedure is best suited for each patient. Volume enhancement with the use of fat and fillers and muscle manipulation with the use of neuromodulators are discussed. A brief summary of currently available skin-resurfacing techniques is also discussed.
-
References
- 1 Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871
- 2 Pitanguy I. Indications for and treatment of frontal and glabellar wrinkles in an analysis of 3,404 consecutive cases of rhytidectomy. Plast Reconstr Surg 1981; 67: 157-168
- 3 Tolhurst DE, Carstens MH, Greco RJ, Hurwitz DJ. The surgical anatomy of the scalp. Plast Reconstr Surg 1991; 87: 603-612 , discussion 613–614
- 4 Isse NG, Elahi MM. The corrugator supercilii muscle revisited. Aesthet Surg J 2001; 21: 209-215
- 5 Fagien S. Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin type A. Plast Reconstr Surg 2004; 114: 1892-1902
- 6 Kikkawa DO, Lemke BN, Dortzbach RK. Relations of the superficial musculoaponeurotic system to the orbit and characterization of the orbitomalar ligament. Ophthal Plast Reconstr Surg 1996; 12: 77-88
- 7 Muzaffar AR, Mendelson BC, Adams Jr WP. Surgical anatomy of the ligamentous attachments of the lower lid and lateral canthus. Plast Reconstr Surg 2002; 110: 873-884 , discussion 897–911
- 8 Hoenig JA, Shorr NS, Shorr J. The suborbicularis oculi fat in aesthetic and reconstructive surgery. Int Ophthalmol Clin 1997; 37: 179-191
- 9 Hoenig JA, Shorr NS, Goldberg R. The versatile SOOF lift in oculoplastic surgery. Facial Plast Surg Clin North Am 1998; 6: 205-219
- 10 Pessa JE, Desvigne LD, Lambros VS, Nimerick J, Sugunan B, Zadoo VP. Changes in ocular globe-to-orbital rim position with age: implications for aesthetic blepharoplasty of the lower eyelids. Aesthetic Plast Surg 1999; 23: 337-342
- 11 Carruthers JA, Lowe NJ, Menter MA , et al; BOTOX Glabellar Lines I Study Group. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46: 840-849
- 12 Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N. Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003; 112: 1089-1098
- 13 Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol 2002; 138: 510-514
- 14 Garcia A, Fulton Jr JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg 1996; 22: 39-43
- 15 Kane M, Donofrio L, Ascher B , et al. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations. J Drugs Dermatol 2010; 9 (1, Suppl): s7-s22 , quiz s23–s25
- 16 Hexsel DM, De Almeida AT, Rutowitsch M , et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg 2003; 29: 523-529 , discussion 529
- 17 Lowe NJ. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 1998; 24: 1216-1218
- 18 Odergren T, Hjaltason H, Kaakkola S , et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1998; 64: 6-12
- 19 Kane MA, Brandt F, Rohrich RJ, Narins RS, Monheit GD, Huber MB ; Reloxin Investigational Group. Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg 2009; 124: 1619-1629
- 20 XEOMIN [package insert]. Greensboro, NC: Merz Pharmaceuticals; 2010
- 21 Sami MS, Soparkar CN, Patrinely JR, Hollier LM, Hollier LH. Efficacy of botulinum toxin type a after topical anesthesia. Ophthal Plast Reconstr Surg 2006; 22: 448-452
- 22 Coleman SR. Structural fat grafts: the ideal filler?. Clin Plast Surg 2001; 28: 111-119
- 23 Klein JA. The tumescent technique for liposuction surgery. J Am Acad Cosmet Surg 1987; 4: 263-267
- 24 Lambros V. A technique for filling the temples with highly diluted hyaluronic acid: the “dilution solution.”. Aesthet Surg J 2011; 31: 89-94
- 25 Edwards PC, Fantasia JE. Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers. Clin Interv Aging 2007; 2: 509-519
- 26 Dayan SH, Arkins JP, Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg 2011; 27: 23-28
- 27 Soparkar CN, Patrinely JR. Managing inflammatory reaction to Restylane. Ophthal Plast Reconstr Surg 2005; 21: 151-153
- 28 Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthet Surg J 2002; 22: 555-557
- 29 Peter S, Mennel S. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane). Clin Experiment Ophthalmol 2006; 34: 363-364
- 30 Park SH, Sun HJ, Choi KS. Sudden unilateral visual loss after autologous fat injection into the nasolabial fold. Clin Ophthalmol 2008; 2: 679-683
- 31 Hoenig JA, Morrow D. Patient evaluation. In: Carniol PJ, , Ed. Laser Skin Rejuvenation. Philadelphia, PA: Lippincott; 1997
- 32 Lodhi A, Huzaira M, Khatri KA. Erbium:YAG laser skin resurfacing: a Pakistani experience. J Cosmet Laser Ther 2003; 5: 43-49
- 33 Manstein D, Herron GS, Sink RKH, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-438
- 34 Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med 2006; 38: 169-176
- 35 Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med 2009; 41: 179-184
- 36 Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15 (4 Pt 2) 836-859
- 37 Hoenig JA, Shorr NS, Morrow DM. Chemical peel: eyelid and facial skin rejuvenation. In: Fagien S, , Ed. Putterman's Cosmetic and Oculoplastic Surgery. New York: Elsevier; 2007